Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568409 | PMC |
| http://dx.doi.org/10.1016/j.jdin.2022.05.014 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Reply to "Pityriasis rosea during COVID-19 and its pathogenesis".
JAAD Int
December 2022
Department of Dermatology, George Washington University, Washington, District of Columbia.
Reply to 'A case of pityriasis lichenoides et varioliformis acuta developed after first dose of Oxford-AstraZeneca COVID-19 vaccine'.
J Eur Acad Dermatol Venereol
February 2023
Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Authors' reply to comment by Ciccarese et al. regarding 'Negative SARS-CoV-2 antibodies in patients with positive immunohistochemistry for spike protein in pityriasis rosea-like eruptions'.
J Eur Acad Dermatol Venereol
January 2023
Facultad de Medicina Unidad Saltillo, Universidad Autónoma de Coahuila, Saltillo, Coahuila, Mexico.
Reply to "the significance of investigating clinical, histopathologic and virological features in pityriasis rosea and pityriasis rosea-like eruptions following COVID-19 vaccinations" by Ciccarese G. et al.
Dermatol Ther
August 2022
Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.
Reply to: comment on “Is there a relationship between environmental factors and pityriasis rosea?”.
Acta Dermatovenerol Alp Pannonica Adriat
December 2019
Department of Dermatology, Dr. V. P. Medical College, Hospital and Research Centre, Nashik, Maharashtra, India
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!